JP5922111B2 - 充血剤注入と同時に血圧測定を行う診断目的の動脈用複合カテーテル - Google Patents
充血剤注入と同時に血圧測定を行う診断目的の動脈用複合カテーテル Download PDFInfo
- Publication number
- JP5922111B2 JP5922111B2 JP2013515900A JP2013515900A JP5922111B2 JP 5922111 B2 JP5922111 B2 JP 5922111B2 JP 2013515900 A JP2013515900 A JP 2013515900A JP 2013515900 A JP2013515900 A JP 2013515900A JP 5922111 B2 JP5922111 B2 JP 5922111B2
- Authority
- JP
- Japan
- Prior art keywords
- catheter
- pressure
- infusion
- pressure sensor
- blood flow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000001802 infusion Methods 0.000 title claims description 81
- 239000002131 composite material Substances 0.000 title claims description 22
- 206010020565 Hyperaemia Diseases 0.000 title description 39
- 230000036772 blood pressure Effects 0.000 title description 11
- 230000017531 blood circulation Effects 0.000 claims description 64
- 230000000544 hyperemic effect Effects 0.000 claims description 25
- 208000031481 Pathologic Constriction Diseases 0.000 claims description 23
- 208000037804 stenosis Diseases 0.000 claims description 23
- 230000036262 stenosis Effects 0.000 claims description 23
- 239000003795 chemical substances by application Substances 0.000 claims description 22
- PGAVKCOVUIYSFO-XVFCMESISA-N UTP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-XVFCMESISA-N 0.000 claims description 20
- 229950010342 uridine triphosphate Drugs 0.000 claims description 20
- PGAVKCOVUIYSFO-UHFFFAOYSA-N uridine-triphosphate Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-UHFFFAOYSA-N 0.000 claims description 20
- 210000001367 artery Anatomy 0.000 claims description 19
- 238000002347 injection Methods 0.000 claims description 18
- 239000007924 injection Substances 0.000 claims description 18
- 238000003780 insertion Methods 0.000 claims description 5
- 230000037431 insertion Effects 0.000 claims description 5
- 238000002405 diagnostic procedure Methods 0.000 claims description 2
- 210000003462 vein Anatomy 0.000 claims description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 49
- 210000004351 coronary vessel Anatomy 0.000 description 48
- 238000000034 method Methods 0.000 description 33
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 25
- 229960005305 adenosine Drugs 0.000 description 24
- 238000005259 measurement Methods 0.000 description 18
- 229940090044 injection Drugs 0.000 description 17
- 238000001990 intravenous administration Methods 0.000 description 13
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 12
- 239000003814 drug Substances 0.000 description 12
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 12
- 229940079593 drug Drugs 0.000 description 11
- 230000000694 effects Effects 0.000 description 9
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 8
- 210000000709 aorta Anatomy 0.000 description 8
- 230000004872 arterial blood pressure Effects 0.000 description 8
- 229940124549 vasodilator Drugs 0.000 description 8
- 239000003071 vasodilator agent Substances 0.000 description 8
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 7
- 229930008281 A03AD01 - Papaverine Natural products 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 238000009530 blood pressure measurement Methods 0.000 description 6
- 229960001789 papaverine Drugs 0.000 description 6
- 230000009885 systemic effect Effects 0.000 description 6
- 208000029078 coronary artery disease Diseases 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 5
- 229960001456 adenosine triphosphate Drugs 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 230000010412 perfusion Effects 0.000 description 4
- 238000002399 angioplasty Methods 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000012377 drug delivery Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 238000001361 intraarterial administration Methods 0.000 description 3
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 3
- 229910052753 mercury Inorganic materials 0.000 description 3
- 206010060965 Arterial stenosis Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 210000001105 femoral artery Anatomy 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 210000002254 renal artery Anatomy 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 208000016444 Benign adult familial myoclonic epilepsy Diseases 0.000 description 1
- 208000001778 Coronary Occlusion Diseases 0.000 description 1
- 206010011086 Coronary artery occlusion Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000007177 Left Ventricular Hypertrophy Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 244000208734 Pisonia aculeata Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 206010047163 Vasospasm Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229940068274 adenosine injection Drugs 0.000 description 1
- 238000002583 angiography Methods 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000002586 coronary angiography Methods 0.000 description 1
- 238000007887 coronary angioplasty Methods 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000016427 familial adult myoclonic epilepsy Diseases 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- ZGNITFSDLCMLGI-UHFFFAOYSA-N flubendiamide Chemical compound CC1=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C1NC(=O)C1=CC=CC(I)=C1C(=O)NC(C)(C)CS(C)(=O)=O ZGNITFSDLCMLGI-UHFFFAOYSA-N 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000002608 intravascular ultrasound Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 210000004088 microvessel Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229960003753 nitric oxide Drugs 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000002966 stenotic effect Effects 0.000 description 1
- CCEKAJIANROZEO-UHFFFAOYSA-N sulfluramid Chemical group CCNS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F CCEKAJIANROZEO-UHFFFAOYSA-N 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/0215—Measuring pressure in heart or blood vessels by means inserted into the body
- A61B5/02152—Measuring pressure in heart or blood vessels by means inserted into the body specially adapted for venous pressure
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35785710P | 2010-06-23 | 2010-06-23 | |
| US61/357,857 | 2010-06-23 | ||
| PCT/EP2011/060548 WO2011161212A1 (en) | 2010-06-23 | 2011-06-23 | Combined flow directed intraarterial microcatheter for the infusion of hyperemic agent and concomitant pressure measurements for diagnostic purposes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013534845A JP2013534845A (ja) | 2013-09-09 |
| JP2013534845A5 JP2013534845A5 (enExample) | 2014-08-07 |
| JP5922111B2 true JP5922111B2 (ja) | 2016-05-24 |
Family
ID=44503750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013515900A Expired - Fee Related JP5922111B2 (ja) | 2010-06-23 | 2011-06-23 | 充血剤注入と同時に血圧測定を行う診断目的の動脈用複合カテーテル |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP5922111B2 (enExample) |
| WO (1) | WO2011161212A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2478338C2 (ru) | 2008-09-11 | 2013-04-10 | Эсист Медикал Системз, Инк. | Устройство и способ доставки физиологического датчика |
| SE535022C2 (sv) | 2010-06-30 | 2012-03-20 | St Jude Medical Systems Ab | Sensorguidewire innefattande en sensorkapsel med multipla hål |
| EP2706908B1 (en) | 2011-05-11 | 2019-07-10 | Acist Medical Systems, Inc. | Intravascular sensing system |
| JP6393275B2 (ja) * | 2012-12-21 | 2018-09-19 | ボルケーノ コーポレイション | 脈管内圧力監視装置と共に使用する無線インターフェース装置、システム、および方法 |
| US10130269B2 (en) | 2013-11-14 | 2018-11-20 | Medtronic Vascular, Inc | Dual lumen catheter for providing a vascular pressure measurement |
| US9877660B2 (en) * | 2013-11-14 | 2018-01-30 | Medtronic Vascular Galway | Systems and methods for determining fractional flow reserve without adenosine or other pharmalogical agent |
| EP3068287A1 (en) * | 2013-11-15 | 2016-09-21 | Acist Medical Systems, Inc. | Multi-sensor lesion assessment device and method |
| WO2015077328A1 (en) * | 2013-11-22 | 2015-05-28 | Volcano Corporation | Sensor mounting assembly for sensored guidewire and associated devices, systems, and methods |
| US9913585B2 (en) | 2014-01-15 | 2018-03-13 | Medtronic Vascular, Inc. | Catheter for providing vascular pressure measurements |
| US10244951B2 (en) | 2014-06-10 | 2019-04-02 | Acist Medical Systems, Inc. | Physiological sensor delivery device and method |
| US11330989B2 (en) | 2014-06-16 | 2022-05-17 | Medtronic Vascular, Inc. | Microcatheter sensor design for mounting sensor to minimize induced strain |
| US10201284B2 (en) | 2014-06-16 | 2019-02-12 | Medtronic Vascular Inc. | Pressure measuring catheter having reduced error from bending stresses |
| US10973418B2 (en) | 2014-06-16 | 2021-04-13 | Medtronic Vascular, Inc. | Microcatheter sensor design for minimizing profile and impact of wire strain on sensor |
| WO2016034967A1 (en) * | 2014-09-04 | 2016-03-10 | Koninklijke Philips N.V. | Pressure-sensing intravascular devices, systems, and methods with wrapped pressure-sensing component |
| US10194812B2 (en) | 2014-12-12 | 2019-02-05 | Medtronic Vascular, Inc. | System and method of integrating a fractional flow reserve device with a conventional hemodynamic monitoring system |
| JP6641381B2 (ja) * | 2015-02-26 | 2020-02-05 | セント ジュード メディカル コーディネイション センター ベーファウベーアー | 自己濡れ性管を有する圧力センサおよびガイドワイヤ |
| JP6596228B2 (ja) * | 2015-04-28 | 2019-10-23 | フクダ電子株式会社 | 心臓カテーテル検査装置及び心臓カテーテル検査装置の作動方法 |
| JP6750925B2 (ja) * | 2015-11-04 | 2020-09-02 | アジア パシフィック メディカル テクノロジー ディベロップメント カンパニー，リミテッド | 血管内のコンダクタンスを定量化するためのシステム |
| US11272850B2 (en) | 2016-08-09 | 2022-03-15 | Medtronic Vascular, Inc. | Catheter and method for calculating fractional flow reserve |
| US11330994B2 (en) | 2017-03-08 | 2022-05-17 | Medtronic Vascular, Inc. | Reduced profile FFR catheter |
| US10646122B2 (en) | 2017-04-28 | 2020-05-12 | Medtronic Vascular, Inc. | FFR catheter with covered distal pressure sensor and method of manufacture |
| US11219741B2 (en) | 2017-08-09 | 2022-01-11 | Medtronic Vascular, Inc. | Collapsible catheter and method for calculating fractional flow reserve |
| US11235124B2 (en) | 2017-08-09 | 2022-02-01 | Medtronic Vascular, Inc. | Collapsible catheter and method for calculating fractional flow reserve |
| EP3684247A1 (en) * | 2017-09-19 | 2020-07-29 | Corflow Therapeutics AG | Intracoronary characterization of microvascular obstruction (mvo) and myocardial infarction |
| WO2019203895A1 (en) | 2018-04-20 | 2019-10-24 | Acist Medical Systems, Inc. | Assessment of a vessel |
| GB2577472A (en) * | 2018-07-16 | 2020-04-01 | Medsolve Ltd | An intracoronary wire, system and method for evaluating intracoronary flow |
| US11185244B2 (en) | 2018-08-13 | 2021-11-30 | Medtronic Vascular, Inc. | FFR catheter with suspended pressure sensor |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE506135C2 (sv) | 1990-07-11 | 1997-11-17 | Radi Medical Systems | Sensor- och ledarkonstruktion |
| US5628984A (en) * | 1995-07-31 | 1997-05-13 | University Of North Carolina At Chapel Hill | Method of detecting lung disease |
| SE9600334D0 (sv) | 1996-01-30 | 1996-01-30 | Radi Medical Systems | Combined flow, pressure and temperature sensor |
| NZ332426A (en) * | 1996-03-27 | 2000-09-29 | Univ North Carolina | Method of treating diseases involving dysfunction of ciliary movement such as ciliary dyskinesia and infertility with uridine triphosphates (UTP) and related compounds |
| US6565514B2 (en) | 2000-08-25 | 2003-05-20 | Radi Medical Systems Ab | Method and system for determining physiological variables |
| US7720521B2 (en) * | 2004-04-21 | 2010-05-18 | Acclarent, Inc. | Methods and devices for performing procedures within the ear, nose, throat and paranasal sinuses |
| US7775988B2 (en) | 2005-09-30 | 2010-08-17 | Radi Medical Systems Ab | Method for determining the blood flow in a coronary artery |
| CN101983031A (zh) * | 2008-03-05 | 2011-03-02 | 罗伯特·霍克 | 压力传感导管 |
| RU2478338C2 (ru) * | 2008-09-11 | 2013-04-10 | Эсист Медикал Системз, Инк. | Устройство и способ доставки физиологического датчика |
| KR20120050475A (ko) | 2009-08-10 | 2012-05-18 | 피투-사이언스 에이피에스 | 협착증 및 제한된 혈류의 기타 상태를 진단하기 위한 ｕｔｐ |
-
2011
- 2011-06-23 WO PCT/EP2011/060548 patent/WO2011161212A1/en not_active Ceased
- 2011-06-23 JP JP2013515900A patent/JP5922111B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013534845A (ja) | 2013-09-09 |
| WO2011161212A1 (en) | 2011-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5922111B2 (ja) | 充血剤注入と同時に血圧測定を行う診断目的の動脈用複合カテーテル | |
| US8715200B2 (en) | System for determining the blood flow in a coronary artery | |
| US9931041B2 (en) | Method and apparatus for fractional flow reserve measurements | |
| Pijls | Fractional flow reserve to guide coronary revascularization | |
| Pijls et al. | Practice and potential pitfalls of coronary pressure measurement | |
| JP2024020363A (ja) | ハイブリッドな画像－侵襲性－圧力血行動態機能評価 | |
| US20150133799A1 (en) | Systems and methods for determining fractional flow reserve without adenosine or other pharmalogical agent | |
| US20140276137A1 (en) | Systems and methods for determining coronary flow reserve | |
| JP7773483B2 (ja) | 患者に関する血管生理学的パラメータを決定するシステムまたは動脈血管を有する患者を診断または処置するためのシステム | |
| Travieso et al. | Invasive evaluation of coronary microvascular dysfunction | |
| Puymirat et al. | Fractional flow reserve: concepts, applications and use in France in 2010 | |
| WO2021035190A1 (en) | Controlled-flow infusion catheter and method | |
| CN116709980A (zh) | 用于确定和/或治疗微血管阻塞的设备和方法 | |
| Kolli et al. | Effect of changes in contractility on pressure drop coefficient and fractional flow reserve in a porcine model | |
| Stoller et al. | Reactive myocardial hyperaemia for functional assessment of coronary stenosis severity | |
| RU2531131C1 (ru) | Способ эндоваскулярного определения функциональной значимости стенозирующих поражений почечных артерий у пациентов с реноваскулярной гипертензией | |
| CUSACK | Pressure wire and related technologies | |
| Ragosta | CORONARY AND PERIPHERAL ARTERY HEMODYNAMICS | |
| SERRUYS et al. | Assessment of coronary flow reserve during angioplasty using a Doppler tip balloon catheter. Comparison with digital subtraction cineangiography | |
| Kern et al. | Application of intracoronary physiology: Use of pressure and flow measurements | |
| Mario et al. | Intracoronary blood flow velocity and transstenotic pressure gradient using sensor‐tip pressure and doppler guidewires: A new technology for the assessment of stenosis severity in the catheterization laboratory | |
| JPWO2022149106A5 (enExample) | ||
| Hau | Fractional Flow Reserve: Overview and Implications for Clinical Decision Making | |
| Osama Elshahawy et al. | Fractional Flow Reserve Assessed by Pressure Wire and Proper Stent Deployment | |
| Blair et al. | Assessment of coronary blood flow in the cardiac catheterization laboratory |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140619 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140619 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20150116 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150309 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20150603 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150909 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160314 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160413 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5922111 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |